ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Comparison of Short-Term Outcomes of Induction Therapy with Alemtuzumab versus Rabbit Antithymocyte Globulin in Lung Transplantation

V. Liu, M. W. Soto-Arenall, A. Patel

Pharmacy, Mayo Clinic, Jacksonville, FL

Meeting: 2020 American Transplant Congress

Abstract number: C-300

Keywords: Antilymphocyte antibodies, Graft function, Induction therapy, Lung transplantation

Session Information

Session Name: Poster Session C: Lung: All Topics

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: To identify the short-term efficacy and safety outcomes of alemtuzumab (C1H) versus rabbit antithymocyte globulin (rATG) in lung transplant patients. The objectives are to compare primary graft dysfunction (PGD), time to extubation, and time to hemodynamic stability between the two induction agents.

*Methods: This was a retrospective study conducted at Mayo Clinic. Adult patients who received their initial lung transplant with C1H or rATG at Mayo Clinic from October 2018 to June 2019 were included. Patients were excluded if they received a multi-organ transplant, had a prior transplant, received agents other than study drugs for induction, did not receive a calcineurin inhibitor for maintenance immunosuppression, did not receive anti-infective prophylaxis, or died within 1 month post-transplant. Fisher’s exact test was performed for nominal variables and Mann-Whitney U was used for continuous variables. Statistical significance was achieved when p < 0.05.

*Results: Patients who received C1H for induction had lower incidences of PGD from 0 to 72 hours after transplant compared to the rATG group, but this did not achieve statistical significance. The C1H group retained a lower absolute lymphocyte count 72 hours post-administration compared to the rATG group, which was expected based on the mechanism of C1H. There were no statistically significant differences between the two groups with regards to vasopressor requirements and time to extubation.

*Conclusions: Our data suggests that there is no difference in efficacy and safety with alemtuzumab compared to antithymocyte globulin. A larger sample size will be needed to confirm these results.

 border=

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Liu V, Soto-Arenall MW, Patel A. Comparison of Short-Term Outcomes of Induction Therapy with Alemtuzumab versus Rabbit Antithymocyte Globulin in Lung Transplantation [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/comparison-of-short-term-outcomes-of-induction-therapy-with-alemtuzumab-versus-rabbit-antithymocyte-globulin-in-lung-transplantation/. Accessed May 10, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences